Lv4
540 积分 2022-05-29 加入
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis
19小时前
待确认
Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation
1天前
待确认
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
1天前
待确认
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
1天前
待确认
The prognostic role of Fibrosis-4 score in heart failure with reduced ejection fraction
2天前
已完结
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
2天前
已完结
Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
2天前
已完结
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
2天前
已完结
Reconciling the apparently contrasting observational and genetic evidence on the association between MASLD and cardiovascular disease
2天前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
2天前
已完结
皖公网安备34019202002308
